Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Benzamides
• Diabetic Nephropathies / drug therapy
• Diabetic Nephropathies / enzymology
• Diabetic Nephropathies / surgery
• Female
• Humans
• Imatinib Mesylate
• Kidney Failure, Chronic / drug therapy
• Kidney Failure, Chronic / enzymology
• Kidney Failure, Chronic / surgery
• Kidney Transplantation*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
• Middle Aged
• Piperazines / adverse effects
• Piperazines / therapeutic use*
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use*
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use*
• Time Factors